APA

Suda G., Nakai M., Sho T., Kimura M., Shimazaki T., Maehara O., Shigesawa T., Suzuki K., Nakamura A., Ohara M., Umemura M., Kawagishi N., Baba M., Natsuizaka M., Morikawa K., Ogawa K. & Sakamoto N. (20190528). The Successful Retreatment with Glecaprevir and Pibrentasvir of Genotype 1 or 2 HCV-infected Hemodialysis Patients who Failed to Respond to NS5A and Protease Inhibitor Treatment. : Internal medicine (Tokyo, Japan).

Chicago

Suda Goki, Nakai Masato, Sho Takuya, Kimura Megumi, Shimazaki Tomoe, Maehara Osamu, Shigesawa Taku, Suzuki Kazuharu, Nakamura Akihisa, Ohara Masatsugu, Umemura Machiko, Kawagishi Naoki, Baba Masaru, Natsuizaka Mitsuteru, Morikawa Kenichi, Ogawa Koji and Sakamoto Naoya. 20190528. The Successful Retreatment with Glecaprevir and Pibrentasvir of Genotype 1 or 2 HCV-infected Hemodialysis Patients who Failed to Respond to NS5A and Protease Inhibitor Treatment. : Internal medicine (Tokyo, Japan).

Harvard

Suda G., Nakai M., Sho T., Kimura M., Shimazaki T., Maehara O., Shigesawa T., Suzuki K., Nakamura A., Ohara M., Umemura M., Kawagishi N., Baba M., Natsuizaka M., Morikawa K., Ogawa K. and Sakamoto N. (20190528). The Successful Retreatment with Glecaprevir and Pibrentasvir of Genotype 1 or 2 HCV-infected Hemodialysis Patients who Failed to Respond to NS5A and Protease Inhibitor Treatment. : Internal medicine (Tokyo, Japan).

MLA

Suda Goki, Nakai Masato, Sho Takuya, Kimura Megumi, Shimazaki Tomoe, Maehara Osamu, Shigesawa Taku, Suzuki Kazuharu, Nakamura Akihisa, Ohara Masatsugu, Umemura Machiko, Kawagishi Naoki, Baba Masaru, Natsuizaka Mitsuteru, Morikawa Kenichi, Ogawa Koji and Sakamoto Naoya. The Successful Retreatment with Glecaprevir and Pibrentasvir of Genotype 1 or 2 HCV-infected Hemodialysis Patients who Failed to Respond to NS5A and Protease Inhibitor Treatment. : Internal medicine (Tokyo, Japan). 20190528.